tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Orchard Therapeutics PLC's activity chart (see below) currently has 47 price targets and 43 ratings on display.
Analysts average stock forecasts to be materialized ratio is 21.27% with an average time for these price targets to be met of 67.65 days.
Most recent stock forecast was given by DAE GON HA from STIFEL on 05-Oct-2023. First documented stock forecast 26-Nov-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2021
$16
$-0.7 (-4.19%)
$22
3 years 7 days ago
(05-Oct-2023)
1/4 (25%)
$0.05 (0.31%)
1
Buy Since 14-Sep-2020
$34
$17.3 (103.59%)
$34
3 years 2 months 3 days ago
(09-Aug-2023)
0/4 (0%)
$28.94 (571.94%)
Buy Since 29-Dec-2021
$15
$-1.7 (-10.18%)
$15
3 years 3 months 15 days ago
(27-Jun-2023)
3/3 (100%)
$9.77 (186.81%)
107
Buy Since 18-Jul-2022
$37
$20.3 (121.56%)
$50
3 years 6 months 29 days ago
(13-Mar-2023)
0/2 (0%)
$32.05 (647.47%)
Buy Since 05-Sep-2019
$13
4 years 4 months 29 days ago
(13-May-2022)
2/2 (100%)
$-34.2 (-72.46%)
621
What is ORTX (Orchard Therapeutics PLC) average time for price targets to be met?
Which analyst most recently updated their price target on ORTX (Orchard Therapeutics PLC)?
Which analyst has the most public recommendations on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most bullish on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most reserved on ORTX (Orchard Therapeutics PLC)?
